NGNE Neurogene

• None no insider bought on the open market
• None no sales outside a trading plan
• $902K sold by 2 insiders under 10b5-1 plans

1. Insider
   Trade
   Value
   Traded, filed
2. Christine Mikail Cvijic CFO
   Planned sale
   $173K 4,800 shares at $36.12 5.4% of stake
   Traded Jul 6–7 Filed Jul 7
   ↗
3. Christine Mikail Cvijic CFO
   Planned sale
   $167K 4,800 shares at $34.71 5.1% of stake
   Traded Jul 1–2 Filed Jul 2
   ↗
4. Christine Mikail Cvijic CFO
   Planned sale
   $300K 9,600 shares at $31.25 9.3% of stake
   Traded May 6 Filed May 8
   ↗
5. Stuart Cobb Chief Scientific Officer
   Planned sale
   $141K 6,797 shares at $20.81 18% of stake
   Traded Mar 13 Filed Mar 17
   ↗
6. Christine Mikail Cvijic CFO
   Planned sale
   $121K 4,800 shares at $25.11 4.2% of stake
   Traded Feb 27 Filed Mar 3
   ↗

Also filed in the last 12 months, not counted as buying or selling: 6 sales to cover taxes, 4 stock grants, and 1 option exercise.